\-\ Texto\\:\\ \ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ na\\ 142\ \(0\)\
\-\ cl\\ 108\ \(0\)\
\-\ co2\\ 25\ \(0\)\
\-\ glu\\ 104\ \(0\)\
\-\ bun\\ 21\ \(0\)\
\-\ cr\\ 1\\.1\ \(0\)\
\-\ ca\\ 9\\.6\ \(0\)\
\-\ alk\\ phos\\ 81\ \(0\)\
\-\ iron\\ 27\ \(0\)\
\-\ tibc\\ 222\ \(0\)\
\-\ ironsat\\ 12\\.2\ \(0\)\
\-\ ferritin\\ 250\ \(0\)\
\-\ pth\\ 61\\.0\ \(0\)\
\-\ axial\\ flair\\,\\ t1\\,\\ and\\ t2\\ mr\\ images\\ through\\ the\\ brain\\ demonstrate\\ mixed\\ high\\ and\\ low\\ t1\\ signal\\ abnormalities\\ in\\ the\\ dentate\\ nuclei\\ of\\ the\\ cerebellum\\,\\ caudate\\ nuclei\\,\\ pallidum\\ and\\ thalami\\.\\ \\ these\\ lesions\\ are\\ fairly\\ symmetric\\,\\ and\\ correspond\\ to\\ \\ areas\\ of\\ calcification\\ seen\\ on\\ previous\\ ct\\.\ \(0\)\
\-\ fahr\\ disease\ \(0\)\
\-\ basal\\ ganglia\\ calcification\ \(8\)\
\-\ idiopathic\\/physiologic\ \(0\)\
\-\ endocrine\ \(38\)\
\-\ \\Â\\»pseudohypoparathyroidism\\ and\\ hypoparathyroidism\ \(0\)\
\-\ \\Â\\»hyperparathyroidism\ \(0\)\
\-\ \\Â\\»hypothyroidism\ \(0\)\
\-\ metabolic\ \(105\)\
\-\ \\Â\\»fahr\ \(0\)\
\-\ \\Â\\»leigh\ \(0\)\
\-\ \\Â\\»mitochondrial\\ cytopathies\ \(0\)\
\-\ congenital\\/developmental\\:\\ \ \(0\)\
\-\ \\Â\\»tuberous\\ sclerosis\\ \ \(0\)\
\-\ \\Â\\»down\\ syndrome\\ \ \(0\)\
\-\ \\Â\\»neurofibromatosis\\ \ \(0\)\
\-\ \\Â\\»familial\\ idiopathic\\ symmetric\\ basal\\ ganglia\\ calcification\\ \ \(0\)\
\-\ \\Â\\»hastings\\-james\\ syndrome\\ \ \(0\)\
\-\ \\Â\\»cockayne\\ syndrome\\ \ \(0\)\
\-\ \\Â\\»lipoid\\ proteinosis\\ \ \(0\)\
\-\ \\Â\\»oculocraniosomatic\\ disease\\ \ \(0\)\
\-\ \\Â\\»methemoglobinopathy\\ \ \(0\)\
\-\ postinfectious\\/inflammatory\\:\\ \ \(0\)\
\-\ \\Â\\»congenital\\ \\(torch\\)\\ infections\ \(0\)\
\-\ \\Â\\»neurocysticercosis\ \(0\)\
\-\ \\Â\\»hiv\ \(0\)\
\-\ \\Â\\»measles\ \(0\)\
\-\ \\Â\\»varicella\ \(0\)\
\-\ \\Â\\»pertussis\\ \ \(0\)\
\-\ \\Â\\»coxsackie\\ b\\ virus\ \(0\)\
\-\ \\Â\\»systemic\\ lupus\\ erythematosus\ \(0\)\
\-\ toxic\\:\\ \ \(1\)\
\-\ \\Â\\»childhood\\ leukemia\\ following\\ methotrexate\\ therapy\\ \ \(0\)\
\-\ \\Â\\»status\\ post\\ xrt\\ \ \(0\)\
\-\ \\Â\\»carbon\\ monoxide\\ poisoning\\ \ \(0\)\
\-\ \\Â\\»lead\\ intoxication\\ \ \(0\)\
\-\ \\Â\\»nephrotic\\ syndrome\\ \ \(0\)\
\-\ anoxic\\:\\ \ \(0\)\
\-\ \\Â\\»birth\\ anoxia\\ \ \(0\)\
\-\ \\Â\\»birth\\ hypoxia\\ \ \(0\)\
\-\ \\Â\\»status\\ post\\-cardiovascular\\ event\ \(0\)\
\-\ 64\\ year\\ old\\ male\\ with\\ symptoms\\ of\\ tia\ \(0\)\
\-\ fahr\\ disease\\,\\ or\\ cerebrovascular\\ ferrocalcinosis\\,\\ is\\ an\\ uncommon\\ disorder\\ characterized\\ by\\ extensive\\ basal\\ ganglia\\ calcification\\,\\ and\\ includes\\ familial\\ and\\ idiopathic\\ forms\\.\\ \\ in\\ this\\ case\\,\\ mr\\ images\\ of\\ this\\ patient\\ are\\ submitted\\ to\\ supplement\\ an\\ earlier\\ submission\\ of\\ ct\\ images\\ from\\ the\\ same\\ patient\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.5179396641957563\ \(0\)\
\-\ fahr\\:\\ 0\\.08578667275633807\ \(0\)\
\-\ ganglia\\:\\ 0\\.05205794246995454\ \(0\)\
\-\ calcification\\:\\ 0\\.04923469235646236\ \(0\)\
\-\ basal\\:\\ 0\\.046375446406409206\ \(0\)\
\-\ nuclei\\:\\ 0\\.04245859143783152\ \(0\)\
\-\ familial\\:\\ 0\\.041523805440558635\ \(0\)\
\-\ syndrome\\:\\ 0\\.03879216788467685\ \(0\)\
\-\ 222\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ ironsat\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ 61\\.0\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ idiopathic\\/physiologic\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ cytopathies\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ hastings\\-james\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ cockayne\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ oculocraniosomatic\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ methemoglobinopathy\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ postinfectious\\/inflammatory\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ coxsackie\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ post\\-cardiovascular\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ ferrocalcinosis\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ birth\\:\\ 0\\.03258720811630289\ \(0\)\
\-\ pallidum\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ congenital\\/developmental\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ symmetric\\:\\ 0\\.03097510744627338\ \(0\)\
\-\ idiopathic\\:\\ 0\\.030916964270939467\ \(0\)\
\-\ 108\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ pseudohypoparathyroidism\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ anoxia\\:\\ 0\\.03062264339404122\ \(0\)\
\-\ 142\\:\\ 0\\.029481047868438918\ \(0\)\
\-\ lipoid\\:\\ 0\\.029481047868438918\ \(0\)\
\-\ supplement\\:\\ 0\\.029481047868438918\ \(0\)\
\-\ tibc\\:\\ 0\\.028595557585446022\ \(0\)\
\-\ 12\\.2\\:\\ 0\\.028595557585446022\ \(0\)\
\-\ hypoparathyroidism\\:\\ 0\\.028595557585446022\ \(0\)\
\-\ pertussis\\:\\ 0\\.028595557585446022\ \(0\)\
\-\ nephrotic\\:\\ 0\\.028595557585446022\ \(0\)\
\-\ dentate\\:\\ 0\\.02787205934420017\ \(0\)\
\-\ glu\\:\\ 0\\.027260350297266606\ \(0\)\
\-\ ferritin\\:\\ 0\\.027260350297266606\ \(0\)\
\-\ mitochondrial\\:\\ 0\\.027260350297266606\ \(0\)\
\-\ measles\\:\\ 0\\.027260350297266606\ \(0\)\
\-\ proteinosis\\:\\ 0\\.026730463818597863\ \(0\)\
\-\ 9\\.6\\:\\ 0\\.02626307081996142\ \(0\)\
\-\ leigh\\:\\ 0\\.02626307081996142\ \(0\)\
\-\ varicella\\:\\ 0\\.02626307081996142\ \(0\)\
\-\ cerebrovascular\\:\\ 0\\.02626307081996142\ \(0\)\
\-\ 250\\:\\ 0\\.025844973535604967\ \(0\)\
\-\ neurocysticercosis\\:\\ 0\\.02546675853638146\ \(0\)\
\-\ intoxication\\:\\ 0\\.02546675853638146\ \(0\)\
\-\ anoxic\\:\\ 0\\.025121475294359114\ \(0\)\
\-\ monoxide\\:\\ 0\\.02450976624742555\ \(0\)\
\-\ correspond\\:\\ 0\\.02423598501136622\ \(0\)\
\-\ poisoning\\:\\ 0\\.02423598501136622\ \(0\)\
\-\ status\\:\\ 0\\.024208946993505186\ \(0\)\
\-\ 104\\:\\ 0\\.02397987976875681\ \(0\)\
\-\ torch\\:\\ 0\\.02397987976875681\ \(0\)\
\-\ tia\\:\\ 0\\.02397987976875681\ \(0\)\
\-\ submission\\:\\ 0\\.02397987976875681\ \(0\)\
\-\ carbon\\:\\ 0\\.02351248677012037\ \(0\)\
\-\ pth\\:\\ 0\\.023094389485763915\ \(0\)\
\-\ erythematosus\\:\\ 0\\.023094389485763915\ \(0\)\
\-\ xrt\\:\\ 0\\.023094389485763915\ \(0\)\
\-\ cl\\:\\ 0\\.022900777723186803\ \(0\)\
\-\ caudate\\:\\ 0\\.022716174486540404\ \(0\)\
\-\ \\:\\:\\ 0\\.0224260876188624\ \(0\)\
\-\ virus\\:\\ 0\\.02220889920277102\ \(0\)\
\-\ 81\\:\\ 0\\.02205326145216276\ \(0\)\
\-\ co2\\:\\ 0\\.0217591821975845\ \(0\)\
\-\ methotrexate\\:\\ 0\\.021619930928492157\ \(0\)\
\-\ mr\\:\\ 0\\.021549202158305032\ \(0\)\
\-\ t1\\:\\ 0\\.02149599631924003\ \(0\)\
\-\ hypoxia\\:\\ 0\\.021485400961525167\ \(0\)\
\-\ iron\\:\\ 0\\.02135528261698949\ \(0\)\
\-\ thalami\\:\\ 0\\.02135528261698949\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.021107185962301656\ \(0\)\
\-\ endocrine\\:\\ 0\\.020988721822818794\ \(0\)\
\-\ cr\\:\\ 0\\.020343805435922863\ \(0\)\
\-\ submitted\\:\\ 0\\.02005681868362276\ \(0\)\
\-\ lupus\\:\\ 0\\.019965590436699352\ \(0\)\
\-\ fairly\\:\\ 0\\.019876412437286422\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.019876412437286422\ \(0\)\
\-\ toxic\\:\\ 0\\.019876412437286422\ \(0\)\
\-\ alk\\:\\ 0\\.019789194553481756\ \(0\)\
\-\ phos\\:\\ 0\\.019789194553481756\ \(0\)\
\-\ forms\\:\\ 0\\.019703852469271584\ \(0\)\
\-\ images\\:\\ 0\\.019515046332730403\ \(0\)\
\-\ childhood\\:\\ 0\\.019080100153706456\ \(0\)\
\-\ hiv\\:\\ 0\\.01880151182563801\ \(0\)\
\-\ bun\\:\\ 0\\.01873481691168412\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.01873481691168412\ \(0\)\
\-\ event\\:\\ 0\\.01873481691168412\ \(0\)\
\-\ tuberous\\:\\ 0\\.018669224443623757\ \(0\)\
\-\ 64\\:\\ 0\\.018478711669074704\ \(0\)\
\-\ na\\:\\ 0\\.018296927795934653\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.017796766205080028\ \(0\)\
\-\ leukemia\\:\\ 0\\.0173996096235047\ \(0\)\
\-\ cerebellum\\:\\ 0\\.01686972314483596\ \(0\)\
\-\ characterized\\:\\ 0\\.01686972314483596\ \(0\)\
\-\ metabolic\\:\\ 0\\.01674761338822186\ \(0\)\
\-\ earlier\\:\\ 0\\.01674761338822186\ \(0\)\
\-\ disease\\:\\ 0\\.016627827871615524\ \(0\)\
\-\ uncommon\\:\\ 0\\.016590434268797073\ \(0\)\
\-\ lead\\:\\ 0\\.016258014097902392\ \(0\)\
\-\ systemic\\:\\ 0\\.016222740497040308\ \(0\)\
\-\ infections\\:\\ 0\\.016118762828810054\ \(0\)\
\-\ b\\:\\ 0\\.015984232861843063\ \(0\)\
\-\ ca\\:\\ 0\\.015790621099265954\ \(0\)\
\-\ 27\\:\\ 0\\.015728127619233655\ \(0\)\
\-\ flair\\:\\ 0\\.015546343746093597\ \(0\)\
\-\ 21\\:\\ 0\\.015344279895191784\ \(0\)\
\-\ disorder\\:\\ 0\\.015233272545817156\ \(0\)\
\-\ mixed\\:\\ 0\\.014892553138648934\ \(0\)\
\-\ down\\:\\ 0\\.014555650583940654\ \(0\)\
\-\ same\\:\\ 0\\.013977038092230182\ \(0\)\
\-\ 25\\:\\ 0\\.013707247056575686\ \(0\)\
\-\ includes\\:\\ 0\\.013670160300947759\ \(0\)\
\-\ extensive\\:\\ 0\\.01356093540654264\ \(0\)\
\-\ previous\\:\\ 0\\.01316805634394165\ \(0\)\
\-\ abnormalities\\:\\ 0\\.012455415165469113\ \(0\)\
\-\ congenital\\:\\ 0\\.012401424482708086\ \(0\)\
\-\ sclerosis\\:\\ 0\\.012179822354866447\ \(0\)\
\-\ labs\\:\\ 0\\.011793547646568007\ \(0\)\
\-\ areas\\:\\ 0\\.011410107822405027\ \(0\)\
\-\ post\\:\\ 0\\.010677916797905926\ \(0\)\
\-\ brain\\:\\ 0\\.01020377588612207\ \(0\)\
\-\ axial\\:\\ 0\\.009677743952650282\ \(0\)\
\-\ \\,\\:\\ 0\\.009668216625617405\ \(0\)\
\-\ through\\:\\ 0\\.00963078181913043\ \(0\)\
\-\ following\\:\\ 0\\.009624118082941065\ \(0\)\
\-\ t2\\:\\ 0\\.009597574479168062\ \(0\)\
\-\ ct\\:\\ 0\\.00948653693168288\ \(0\)\
\-\ low\\:\\ 0\\.009429238305025395\ \(0\)\
\-\ an\\:\\ 0\\.009378292573688331\ \(0\)\
\-\ high\\:\\ 0\\.00927994468681276\ \(0\)\
\-\ are\\:\\ 0\\.009245030734361918\ \(0\)\
\-\ lesions\\:\\ 0\\.009077621056920428\ \(0\)\
\-\ therapy\\:\\ 0\\.009066034905716717\ \(0\)\
\-\ signal\\:\\ 0\\.008940771151876106\ \(0\)\
\-\ these\\:\\ 0\\.008824780523642222\ \(0\)\
\-\ symptoms\\:\\ 0\\.008451021733722773\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007803381513226352\ \(0\)\
\-\ this\\:\\ 0\\.007628073121540738\ \(0\)\
\-\ case\\:\\ 0\\.007418668384393931\ \(0\)\
\-\ patient\\:\\ 0\\.006798348658066571\ \(0\)\
\-\ seen\\:\\ 0\\.006700903234395596\ \(0\)\
\-\ male\\:\\ 0\\.006131768007489972\ \(0\)\
\-\ by\\:\\ 0\\.005646313108114582\ \(0\)\
\-\ from\\:\\ 0\\.005025538544262747\ \(0\)\
\-\ and\\:\\ 0\\.00500025015922829\ \(0\)\
\-\ or\\:\\ 0\\.003974296622871855\ \(0\)\
\-\ year\\:\\ 0\\.0037940685288607727\ \(0\)\
\-\ old\\:\\ 0\\.0034719626859613275\ \(0\)\
\-\ to\\:\\ 0\\.003389429432087192\ \(0\)\
\-\ in\\:\\ 0\\.0033444224614305944\ \(0\)\
\-\ on\\:\\ 0\\.0028725833824024922\ \(0\)\
\-\ \\(\\:\\ 0\\.002866514786681986\ \(0\)\
\-\ \\)\\:\\ 0\\.002831498778227401\ \(0\)\
\-\ of\\:\\ 0\\.002311583349166437\ \(0\)\
\-\ is\\:\\ 0\\.0022313126126378\ \(0\)\
\-\ the\\:\\ 0\\.002194433090533743\ \(0\)\
\-\ \\.\\:\\ 0\\.0005634846999578773\ \(0\)\
\-\ with\\:\\ 0\\.000464302286070991\ \(0\)\
